DDPO is an inhibitor for dihydrofolate reductase (DHFR) with an IC 50 of 0.035 µM. DDPO inhibits the cell growth of cancer cell L1210 and WI-L2with IC 50 of 5 and 0.28 µM.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Dihydrofolate reductase (DHFR)
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。